Related Experiment Video
Updated: Feb 20, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
[Rocuronium: onset time or speed of action?]
1Departamento de Anestesia, Hospital Clínicas Caracas, Policlínica Méndez Gimón, Caracas, Venezuela. steinberg@telcel.net.ve
Objective:
Rocuronium has been said to have an initially rapid onset of action followed by a slower final approach to maximum effect, the supporting data showing only that time to 75% of blockade is more rapid. Expressions of velocity are derived from basic measures such as length and time. The aim of our study was to confirm the onset characteristics of rocuronium by using appropriate expressions of velocity.
Patients And Methods:
After consenting, 25 adults scheduled for elective surgery were anesthetized, using a bolus dose of rocuronium of 400 microg Kg(-1) for relaxation. Electromyography was used to determine maximal effect, time to reach 80% of a full neuromuscular block, onset time, the time interval between these two points, and the differential blockade produced during each period. Velocity for each period was calculated as the ratio between the percentage of block produced per amount of time elapsed (%/s) during each respective period. The ratio between time and blockade (s/%) was also calculated.
Results:
More blockade was produced per second (velocity) during the initial period of activity (0.55%/s) than during the final period (0.109%/s). The average velocity during the onset period overall (0.33%/s) lay between those two figures. Rocuronium requires less time (acting fast) to achieve an initial effect (1.95 s/%) than it does to reach the final effect (10.8 s/%). The ratio of early to late speed of onset was 5.8 +/- 3.5.
Conclusion:
Using appropriate expressions and calculations, we can unequivocally conclude that rocuronium has a biphasic onset that is initially rapid and then slower. The rate of action is nearly 6 times faster at the beginning.
More Related Videos
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...

